Calcifying human aortic smooth muscle cells express different bone alkaline phosphatase isoforms, including the novel B1x isoform

Journal of Vascular Research

Volumn 50, Issue 2, 2013, Pages 167-174

  Haarhaus, Mathias ^a,c   Arnqvist, Hans J ^b   Magnusson, Per ^a  

^a Division of Clinical Chemistry   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Bone specific alkaline phosphatase; Chronic kidney disease; Human aortic smooth muscle cells; Isoforms; Phosphate; Vascular calcification

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; GLYCEROL 2 PHOSPHATE; ISOENZYME B I; ISOENZYME B1; ISOENZYME B1X; ISOENZYME B2; TETRAMISOLE; UNCLASSIFIED DRUG;

ARTICLE; BLOOD VESSEL CALCIFICATION; CELL CULTURE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN AORTIC SMOOTH MUSCLE CELL; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER;

ALKALINE PHOSPHATASE; AORTIC DISEASES; CALCINOSIS; CALCIUM; CELLS, CULTURED; ENZYME INDUCTION; ENZYME INHIBITORS; GLYCEROPHOSPHATES; HUMANS; ISOENZYMES; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; ORGAN SPECIFICITY; PHOSPHOLIPASE D; TETRAMISOLE;

EID: 84872264565     PISSN: 10181172     EISSN: 14230135     Source Type: Journal    
DOI: 10.1159/000346161     Document Type: Article

References (50)

1. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305.
2. Moe SM, Drüeke T, Lameire N, Eknoyan G: Chronic kidney disease-mineral-bone disorder: A new paradigm. Adv Chronic Kidney Dis 2007; 14: 3-12.
3. Koleganova N, Piecha G, Ritz E, Schirmacher P, Müller A, Meyer HP, Gross ML: Arterial calcification in patients with chronic kidney disease. Nephrol Dial Transplant 2009; 24: 2488-2496.
4. Mizobuchi M, Towler D, Slatopolsky E: Vascular calcification: the killer of patients with chronic kidney disease. J Am Soc Nephrol 2009; 20: 1453-1464.
5. Nikolov IG, Joki N, Nguyen-Khoa T, Ivanovski O, Phan O, Lacour B, Drueke TB, Massy ZA, Dos Reis LM, Jorgetti V, Lafage-Proust MH: Chronic kidney disease bone and mineral disorder (CKD-MBD) in apolipoprotein E-deficient mice with chronic renal failure. Bone 2010; 47: 156-163.
6. Shioi A, Nishizawa Y, Jono S, Koyama H, Hosoi M, Morii H: Beta-glycerophosphate accelerates calcification in cultured bovine vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 1995; 15: 2003-2009.
7. Jono S, McKee MD, Murry CE, Shioi A, Nishizawa Y, Mori K, Morii H, Giachelli CM: Phosphate regulation of vascular smooth muscle cell calcification. Circ Res 2000; 87:E10-E17.
8. Taylor J, Butcher M, Zeadin M, Politano A, Shaughnessy SG: Oxidized low-density lipoprotein promotes osteoblast differentiation in primary cultures of vascular smooth muscle cells by up-regulating osterix expression in an Msx2-dependent manner. J Cell Biochem 2011; 112: 581-588.
9. Moe SM, Chen NX: Mechanisms of vascular calcification in chronic kidney disease. J Am Soc Nephrol 2008; 19: 213-216.
10. Shroff RC, McNair R, Figg N, Skepper JN, Schurgers L, Gupta A, Hiorns M, Donald AE, Deanfield J, Rees L, Shanahan CM: Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis. Circulation 2008; 118: 1748-1757.
11. Yoshida H, Yokoyama K, Yaginuma T, Ohkido I, Yamamoto H, Utsunomiya Y, Kawakami M, Hosoya T: Difference in coronary artery intima and media calcification in autopsied patients with chronic kidney disease. Clin Nephrol 2011; 75: 1-7.
12. Drechsler C, Verduijn M, Pilz S, Krediet RT, Dekker FW, Wanner C, Ketteler M, Boeschoten EW, Brandenburg V: Bone alkaline phosphatase and mortality in dialysis patients. Clin J Am Soc Nephrol 2011; 6: 1752-1759.
13. Kalantar-Zadeh K, Kuwae N, Regidor DL, Kovesdy CL, Kilpatrick RD, Shinaberger CS, McAllister CJ, Budoff MJ, Salusky IB, Kopple JD: Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int 2006; 70: 771-780.
14. Millán JL: Mammalian Alkaline Phosphatase: from Biology to Applications in Medicine and Biotechnology. Weinheim, Wiley, 2006.
15. Magnusson P, Degerblad M, Sääf M, Larsson L, Thorén M: Different responses of bone alkaline phosphatase isoforms during recombinant insulin-like growth factor-I (IGF-I) and during growth hormone therapy in adults with growth hormone deficiency. J Bone Miner Res 1997; 12: 210-220.
16. Fedde KN, Blair L, Silverstein J, Coburn SP, Ryan LM, Weinstein RS, Waymire K, Narisawa S, Millán JL, MacGregor GR, Whyte MP: Alkaline phosphatase knock-out mice recapitulate the metabolic and skeletal defects of infantile hypophosphatasia. J Bone Miner Res 1999; 14: 2015-2026.
17. Anderson HC, Sipe JB, Hessle L, Dhanyamraju R, Atti E, Camacho NP, Millán JL, Dhamyamraju R: Impaired calcification around matrix vesicles of growth plate and bone in alkaline phosphatase-deficient mice. Am J Pathol 2004; 164: 841-847.
18. Wennberg C, Hessle L, Lundberg P, Mauro S, Narisawa S, Lerner UH, Millán JL: Functional characterization of osteoblasts and osteoclasts from alkaline phosphatase knockout mice. J Bone Miner Res 2000; 15: 1879-1888.
19. Johnson KA, Hessle L, Vaingankar S, Wennberg C, Mauro S, Narisawa S, Goding JW, Sano K, Millan JL, Terkeltaub R: Osteoblast tissue-nonspecific alkaline phosphatase antagonizes and regulates PC-1. Am J Physiol Regul Integr Comp Physiol 2000; 279:R1365-R1377.
20. Magnusson P, Löfman O, Larsson L: Determination of alkaline phosphatase isoenzymes in serum by high-performance liquid chromatography with post-column reaction detection. J Chromatogr 1992; 576: 79-86.
21. Magnusson P, Häger A, Larsson L: Serum osteocalcin and bone and liver alkaline phosphatase isoforms in healthy children and adolescents. Pediatr Res 1995; 38: 955-961.
22. Magnusson P, Larsson L, Englund G, Larsson B, Strang P, Selin-Sjögren L: Differences of bone alkaline phosphatase isoforms in metastatic bone disease and discrepant effects of clodronate on different skeletal sites indicated by the location of pain. Clin Chem 1998; 44: 1621-1628.
23. Magnusson P, Sharp CA, Farley JR: Different distributions of human bone alkaline phosphatase isoforms in serum and bone tissue extracts. Clin Chim Acta 2002; 325: 59-70.
24. Haarhaus M, Fernström A, Magnusson M, Magnusson P: Clinical significance of bone alkaline phosphatase isoforms, including the novel B1x isoform, in mild to moderate chronic kidney disease. Nephrol Dial Transplant 2009; 24: 3382-3389.
25. Magnusson P, Sharp CA, Magnusson M, Risteli J, Davie MWJ, Larsson L: Effect of chronic renal failure on bone turnover and bone alkaline phosphatase isoforms. Kidney Int 2001; 60: 257-265.
26. Magnusson P, Farley JR: Differences in sialic acid residues among bone alkaline phosphatase isoforms: A physical, biochemical, and immunological characterization. Calcif Tissue Int 2002; 71: 508-518.
27. Sharp CA, Linder C, Magnusson P: Analysis of human bone alkaline phosphatase isoforms: Comparison of isoelectric focusing and ion-exchange high-performance liquid chromatography. Clin Chim Acta 2007; 379: 105-112.
28. Magnusson P, Löfman O, Larsson L: Methodological aspects on separation and reaction conditions of bone and liver alkaline phosphatase isoform analysis by high-performance liquid chromatography. Anal Biochem 1993; 211: 156-163.
29. Limas CJ, Cohn JN: Alkaline phosphatase in vascular smooth muscle. Nat New Biol 1973; 245: 53-55.
30. Chen NX, O'Neill KD, Duan D, Moe SM: Phosphorus and uremic serum up-regulate osteopontin expression in vascular smooth muscle cells. Kidney Int 2002; 62: 1724-1731.
31. Shioi A, Katagi M, Okuno Y, Mori K, Jono S, Koyama H, Nishizawa Y: Induction of bonetype alkaline phosphatase in human vascular smooth muscle cells: roles of tumor necrosis factor-and oncostatin M derived from macrophages. Circ Res 2002; 91: 9-16.
32. Cheung BM, Ong KL, Wong LY: Elevated serum alkaline phosphatase and peripheral arterial disease in the United States National Health and Nutrition Examination Survey 1999-2004. Int J Cardiol 2009; 135: 156-161.
33. Tonelli M, Curhan G, Pfeffer M, Sacks F, Thadhani R, Melamed ML, Wiebe N, Muntner P: Relation between alkaline phosphatase, serum phosphate, and all-cause or cardiovascular mortality. Circulation 2009; 120: 1784-1792.
34. Beddhu S, Ma X, Baird B, Cheung AK, Greene T: Serum alkaline phosphatase and mortality in African Americans with chronic kidney disease. Clin J Am Soc Nephrol 2009; 4: 1805-1810.
35. Kovesdy CP, Ureche V, Lu JL, Kalantar-Zadeh K: Outcome predictability of serum alkaline phosphatase in men with pre-dialysis CKD. Nephrol Dial Transplant 2010; 25: 3003-3011.
36. Regidor DL, Kovesdy CP, Mehrotra R, Rambod M, Jing J, McAllister CJ, Van Wyck D, Kopple JD, Kalantar-Zadeh K: Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients. J Am Soc Nephrol 2008; 19: 2193-2203.
37. Sigrist MK, Taal MW, Bungay P, McIntyre CW: Progressive vascular calcification over 2 years is associated with arterial stiffening and increased mortality in patients with stages 4 and 5 chronic kidney disease. Clin J Am Soc Nephrol 2007; 2: 1241-1248.
38. Fahrleitner-Pammer A, Herberth J, Browning SR, Obermayer-Pietsch B, Wirnsberger G, Holzer H, Dobnig H, Malluche HH: Bone markers predict cardiovascular events in chronic kidney disease. J Bone Miner Res 2008; 23: 1850-1858.
39. Kozlenkov A, Le Du MH, Cuniasse P, Ny T, Hoylaerts MF, Millán JL: Residues determining the binding specificity of uncompetitive inhibitors to tissue-nonspecific alkaline phosphatase. J Bone Miner Res 2004; 19: 1862-1872.
40. Halling Linder C, Narisawa S, Millán JL, Magnusson P: Glycosylation differences contribute to distinct catalytic properties among bone alkaline phosphatase isoforms. Bone 2009; 45: 987-993.
41. Olesen P, Nguyen K, Wogensen L, Ledet T, Rasmussen LM: Calcification of human vascular smooth muscle cells: associations with osteoprotegerin expression and acceleration by high-dose insulin. Am J Physiol Heart Circ Physiol 2007; 292:H1058-H1064.
42. Steitz SA, Speer MY, Curinga G, Yang HY, Haynes P, Aebersold R, Schinke T, Karsenty G, Giachelli CM: Smooth muscle cell phenotypic transition associated with calcification: upregulation of Cbfa1 and downregulation of smooth muscle lineage markers. Circ Res 2001; 89: 1147-1154.
43. Montes de Oca A, Madueno JA, Martinez-Moreno JM, Guerrero F, Munoz-Castaneda J, Rodriguez-Ortiz ME, Mendoza FJ, Almaden Y, Lopez I, Rodriguez M, Aguilera-Tejero E: High-phosphate-induced calcification is related to SM22-promoter methylation in vascular smooth muscle cells. J Bone Miner Res 2010; 25: 1996-2005.
44. Oros M, Zavaczki E, Vadasz C, Jeney V, Tosaki A, Lekli I, Balla G, Nagy L, Balla J: Ethanol increases phosphate-mediated mineralization and osteoblastic transformation of vascular smooth muscle cells. J Cell Mol Med 2012; 16: 2219-2226.
45. Prosdocimo DA, Wyler SC, Romani AM, O'Neill WC, Dubyak GR: Regulation of vascular smooth muscle cell calcification by extracellular pyrophosphate homeostasis: synergistic modulation by cyclic AMP and hyperphosphatemia. Am J Physiol Cell Physiol 2010; 298:C702-C713.
46. Sage AP, Lu J, Tintut Y, Demer LL: Hyperphosphatemia-induced nanocrystals upregulate the expression of bone morphogenetic protein-2 and osteopontin genes in mouse smooth muscle cells in vitro. Kidney Int 2011; 79: 414-422.
47. Shroff RC, McNair R, Skepper JN, Figg N, Schurgers LJ, Deanfield J, Rees L, Shanahan CM: Chronic mineral dysregulation promotes vascular smooth muscle cell adaptation and extracellular matrix calcification. J Am Soc Nephrol 2010; 21: 103-112.
48. Lomashvili KA, Garg P, Narisawa S, Millán JL, O'Neill WC: Upregulation of alkaline phosphatase and pyrophosphate hydrolysis: potential mechanism for uremic vascular calcification. Kidney Int 2008; 73: 1024-1030.
49. Shan PF, Lu Y, Cui RR, Jiang Y, Yuan LQ, Liao EY: Apelin attenuates the osteoblastic differentiation of vascular smooth muscle cells. PLoS One 2011; 6:e17938.
50. Leroux-Berger M, Queguiner I, Maciel TT, Ho A, Relaix F, Kempf H: Pathologic calcification of adult vascular smooth muscle cells differs on their crest or mesodermal embryonic origin. J Bone Miner Res 2011; 26: 1543-1553.